These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 31197361

  • 21. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.
    Lightner AL, Pineiro AO, Reese J, Ream J, Nachand D, Adams AC, Dadgar N, Hull T.
    Surgery; 2024 Apr; 175(4):984-990. PubMed ID: 38097485
    [Abstract] [Full Text] [Related]

  • 22. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial.
    de la Portilla F, Alba F, García-Olmo D, Herrerías JM, González FX, Galindo A.
    Int J Colorectal Dis; 2013 Mar; 28(3):313-23. PubMed ID: 23053677
    [Abstract] [Full Text] [Related]

  • 23. First clinical case report of local microinjection of autologous fat and adipose-derived stromal vascular fraction for perianal fistula in Crohn's disease.
    Philandrianos C, Serrero M, Grimaud F, Magalon J, Visée C, Velier M, Francois P, Orsoni P, Magalon G, Grimaud JC, Desjeux A, Véran J, Sabatier F.
    Stem Cell Res Ther; 2018 Jan 10; 9(1):4. PubMed ID: 29321063
    [Abstract] [Full Text] [Related]

  • 24. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
    Schwartz DA, White CM, Wise PE, Herline AJ.
    Inflamm Bowel Dis; 2005 Aug 10; 11(8):727-32. PubMed ID: 16043987
    [Abstract] [Full Text] [Related]

  • 25. Mesenchymal stem cell therapy for Crohn's perianal fistula-a real-world experience.
    White I, Yanai H, Avni I, Slavin M, Naftali T, Tovi S, Dotan I, Wasserberg N.
    Colorectal Dis; 2024 Jan 10; 26(1):102-109. PubMed ID: 38095303
    [Abstract] [Full Text] [Related]

  • 26. Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.
    van Rijn KL, Meima-van Praag EM, Bossuyt PM, D'Haens GR, Gecse KB, Horsthuis K, Snijder HJ, Tielbeek JAW, Buskens CJ, Stoker J.
    J Crohns Colitis; 2022 Jun 24; 16(5):708-716. PubMed ID: 34644395
    [Abstract] [Full Text] [Related]

  • 27. Mesenchymal stem cells for the treatment of complex perianal fistulas in patients with Crohn disease.
    Borycka-Kiciak K, Pietrzak A, Kielar M, Tarnowski W.
    Pol Przegl Chir; 2019 Jun 10; 92(1):38-47. PubMed ID: 32312921
    [Abstract] [Full Text] [Related]

  • 28. Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn's disease.
    Guillo L, Grimaud F, Houser F, Prost C, Jouve E, Philandrianos C, Abellan M, Veran J, Visee C, Beyer-Berjot L, Desjeux A, Dignat-George F, Leone M, Grimaud JC, Sabatier F, Serrero M, Magalon J.
    Stem Cell Res Ther; 2022 Feb 09; 13(1):67. PubMed ID: 35139888
    [Abstract] [Full Text] [Related]

  • 29. Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease.
    Kotze PG, Spinelli A, Warusavitarne J, Di Candido F, Sahnan K, Adegbola SO, Danese S.
    Drugs Today (Barc); 2019 Feb 09; 55(2):95-105. PubMed ID: 30816884
    [Abstract] [Full Text] [Related]

  • 30. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.
    Meng ZW, Baumgart DC.
    Expert Rev Gastroenterol Hepatol; 2020 Jun 09; 14(6):405-410. PubMed ID: 32354239
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study.
    Dawoud C, Widmann KM, Czipin S, Pramhas M, Scharitzer M, Stift A, Harpain F, Riss S.
    Wien Klin Wochenschr; 2024 May 09; 136(9-10):289-294. PubMed ID: 37823920
    [Abstract] [Full Text] [Related]

  • 32. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
    Hukkinen M, Pakarinen MP, Piekkala M, Koivusalo A, Rintala R, Kolho KL.
    J Crohns Colitis; 2014 Aug 09; 8(8):756-62. PubMed ID: 24447625
    [Abstract] [Full Text] [Related]

  • 33. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
    Meima-van Praag EM, van Rijn KL, Wasmann KATGM, Snijder HJ, Stoker J, D'Haens GR, Gecse KB, Gerhards MF, Jansen JM, Dijkgraaf MGW, van der Bilt JDW, Mundt MW, Spinelli A, Danese S, Bemelman WA, Buskens CJ.
    Lancet Gastroenterol Hepatol; 2022 Jul 09; 7(7):617-626. PubMed ID: 35427495
    [Abstract] [Full Text] [Related]

  • 34. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
    Lightner AL, Otero-Pineiro A, Reese J, Ream J, Nachand D, Adams AC, VanDenBossche A, Kurowski JA.
    Inflamm Bowel Dis; 2023 Dec 05; 29(12):1912-1919. PubMed ID: 37263018
    [Abstract] [Full Text] [Related]

  • 35. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
    Strik AS, Löwenberg M, Buskens CJ, B Gecse K, I Ponsioen C, Bemelman WA, D'Haens GR.
    Scand J Gastroenterol; 2019 Apr 05; 54(4):453-458. PubMed ID: 31032686
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M, Xu X, Feng Q, Cui Z, Wang T, Yan Y, Ran Z.
    Dig Dis Sci; 2021 May 05; 66(5):1658-1668. PubMed ID: 32524415
    [Abstract] [Full Text] [Related]

  • 37. Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials.
    Wang H, Jiang HY, Zhang YX, Jin HY, Fei BY, Jiang JL.
    Stem Cell Res Ther; 2023 Apr 26; 14(1):103. PubMed ID: 37101285
    [Abstract] [Full Text] [Related]

  • 38. [A new treatment option for complex perianal fistulas in Crohn's disease patients; development of darvadstrocel (allogeneic expanded adipose-derived mesenchymal stem cells) in Japan].
    Yamaguchi T.
    Nihon Yakurigaku Zasshi; 2024 Apr 26; 159(3):150-155. PubMed ID: 38692877
    [Abstract] [Full Text] [Related]

  • 39. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT-TOPIC trial after 1-year follow-up.
    Lansdorp CA, Buskens CJ, Gecse KB, Löwenberg M, Stoker J, Bemelman WA, D'Haens GRAM, van Hulst RA.
    United European Gastroenterol J; 2022 Mar 26; 10(2):160-168. PubMed ID: 35146959
    [Abstract] [Full Text] [Related]

  • 40. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F.
    Scand J Gastroenterol; 2006 Sep 26; 41(9):1064-72. PubMed ID: 16938720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.